Skip to content
Blerp – Lifestyle
Author:
Incannex Healthcare
Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026
August 12, 2026
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
July 23, 2026
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
June 25, 2026
Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research
March 25, 2026